新闻

CMS: New Drug Application Of Class 1 Innovative Drug Y-3 For Injection For Acute Ischemic Stroke Accepted In China.

11 Dec 2025 19:21

On 11 December 2025, the New Drug Application of Class 1 Innovative Drug Y-3 for Injection, Loberamisal for Injection, has been accepted by National Medical Products Administration of the People's Republic of China...

Attachments:

• CMS-New_Drug_Application_of_Class_1_Innovative_Drug_Y-3_for_Injection_for_AIS_Accepted_in_China.pdf

Source: ShareInvestor Express